Next-generation sequencing identifies germline MRE11A variants as markers of radiotherapy outcomes in muscle-invasive bladder cancer.
Teo MTW, Dyrskjøt L, Nsengimana J, Buchwald C, Snowden H, Morgan J, Jensen JB, Knowles MA, Taylor G, Barrett JH, Borre M, Ørntoft TF, Bishop DT, Kiltie AE.
Teo MTW, et al. Among authors: kiltie ae.
Ann Oncol. 2014 Apr;25(4):877-883. doi: 10.1093/annonc/mdu014. Epub 2014 Mar 12.
Ann Oncol. 2014.
PMID: 24623370
Free PMC article.